Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Leiras offers drug delivery technology:

This article was originally published in Clinica

Executive Summary

Finnish company Leiras is to offer to biotechnology and pharmaceutical companies its proprietary polymer-based drug delivery technology, known as Delvivo. The company, which is part of the German group Schering, says its technology enables active drug ingredients to be released over a long time and at an even rate into the body. There is also the possibility that Leiras would market some products emerging from any deals. The technology is also the basis of Schering's intrauterine system, Mirena, which is sold in 48 countries worldwide, including the US.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts